
Inhibition of acquired-resistance hepatocellular carcinoma cell growth by combining sorafenib with phosphoinositide 3-kinase and rat sarcoma inhibitor
Keywords: مقاومت دارویی; Sorafenib; Hepatocellular carcinoma; Drug resistance; ERK; PI3K; MDR1;